British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
…, H Selsick, AL Sharpley, AG Wade - Journal of …, 2010 - journals.sagepub.com
Sleep disorders are common in the general population and even more so in clinical practice,
yet are relatively poorly understood by doctors and other health care practitioners. These …
yet are relatively poorly understood by doctors and other health care practitioners. These …
The client in psychotherapy
AC Bohart, AG Wade - Bergin and Garfield's handbook of …, 2013 - books.google.com
In recent years there has been a shift toward greater recognition of the client’s role as an
active participant in psychotherapy. In 1994 Bergin and Garfield said,“Another important …
active participant in psychotherapy. In 1994 Bergin and Garfield said,“Another important …
Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes
AG Wade, I Ford, G Crawford… - … medical research and …, 2007 - Taylor & Francis
Objective: Melatonin, the hormone produced nocturnally by the pineal gland, serves as a
circadian time cue and sleep-anticipating signal in humans. With age, melatonin production …
circadian time cue and sleep-anticipating signal in humans. With age, melatonin production …
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter …
AG Wade, M Farmer, G Harari, N Fund… - … interventions in aging, 2014 - Taylor & Francis
Purpose A link between poor sleep quality and Alzheimer’s disease (AD) has recently been
suggested. Since endogenous melatonin levels are already reduced at preclinical AD stages…
suggested. Since endogenous melatonin levels are already reduced at preclinical AD stages…
[HTML][HTML] Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous …
AG Wade, I Ford, G Crawford, A McConnachie, T Nir… - BMC medicine, 2010 - Springer
Background Melatonin is extensively used in the USA in a non-regulated manner for sleep
disorders. Prolonged release melatonin (PRM) is licensed in Europe and other countries for …
disorders. Prolonged release melatonin (PRM) is licensed in Europe and other countries for …
The effect of citalopram in panic disorder
AG Wade, U Lepola, HJ Koponen… - The British journal of …, 1997 - cambridge.org
BackgroundCitalopram is a serotonin reuptake inhibitor which has been demonstrated to be
highly selective and with a superior tolerability profile to the classical tricyclic …
highly selective and with a superior tolerability profile to the classical tricyclic …
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short-and long-term response
AG Wade, G Crawford, I Ford… - … medical research and …, 2011 - Taylor & Francis
Objectives: The authors recently reported on efficacy and safety of prolonged-release
melatonin formulation (PRM; Circadin 2 mg) in elderly insomnia patients. The age cut-off for …
melatonin formulation (PRM; Circadin 2 mg) in elderly insomnia patients. The age cut-off for …
The societal costs of insomnia
AG Wade - Neuropsychiatric disease and treatment, 2010 - Taylor & Francis
Objective Insomnia can be broadly defined as difficulty initiating or maintaining sleep, or sleep
that is not refreshing or of poor quality with negative effect on daytime function. Insomnia …
that is not refreshing or of poor quality with negative effect on daytime function. Insomnia …
A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder
UM Lepola, AG Wade, EV Leinonen… - Journal of Clinical …, 1998 - psychiatrist.com
Background: The objective of this study was to evaluate the efficacy and tolerability of
citalopram in the long-term treatment of adult outpatients with panic disorder with or without …
citalopram in the long-term treatment of adult outpatients with panic disorder with or without …
Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy
…, FA Mahnert, F Rouillon, AG Wade… - The British Journal of …, 2001 - cambridge.org
BackgroundMajor depression is highly recurrent. Antidepressant maintenance treatment has
proven efficacy against recurrent depression.AimsComparison of prophylactic efficacy of …
proven efficacy against recurrent depression.AimsComparison of prophylactic efficacy of …